Hemadri Cements Ltd Stock Price Today (NSE: HEMACEM)
Fundamental Score
Hemadri Cements Ltd Share Price Live NSE/BSE & Institutional Fundamental Analysis
Hemadri Cements Ltd share price today is ₹50.88, up +0.00% on NSE/BSE as of 2 January 2026. Hemadri Cements Ltd (HEMACEM) is a Small-cap company in the Cement & Cement Products sector with a market capitalisation of ₹33.94 (Cr). The 52-week high for HEMACEM share price is ₹N/A and the 52-week low is ₹N/A. The company has a Return on Equity (ROE) of -281.44% and a debt-to-equity ratio of N/A.
Hemadri Cements Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Hemadri Cements Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Financial Analysis of Hemadri Cements Share Price: A Cautionary Note
The cement industry, known for its cyclical nature and capital-intensive operations, is currently experiencing a period of moderate demand growth. This analysis focuses on the financial stability of Hemadri Cements Ltd, specifically examining the implications of its current valuation on the Hemadri Cements share price. The latest available data indicates a share price of ₹50.88.
A primary concern is the company's profitability, or rather, the lack thereof. Hemadri Cements reports a Price-to-Earnings (PE) ratio of "None," signifying either negative earnings or a period of no reported profits. Furthermore, the Return on Capital Employed (ROCE) stands at a deeply concerning -77.44%. This suggests that the company is significantly underperforming in utilizing its capital to generate profits. Such a low, and indeed negative, ROCE directly erodes any potential economic moat Hemadri Cements might possess. A strong moat allows companies to defend their market share and profitability; however, consistent losses severely weaken this competitive advantage. For instance, well-managed peers like
Prism Johnson Ltd demonstrate significantly better operational efficiency and capital allocation as evidenced by their positive ROCE figures, highlighting a stark contrast in management quality.The absence of a PE ratio coupled with a profoundly negative ROCE paints a picture of significant financial distress. While external factors such as fluctuating raw material costs and regional demand variations can impact profitability, a -77.44% ROCE indicates deeper, potentially systemic issues within Hemadri Cements' operations. It raises concerns about the efficiency of its production processes, the effectiveness of its cost management strategies, and its overall ability to compete effectively within the cement sector. These operational inefficiencies could result in investor hesitance, affecting the company's valuation.
Investors should carefully consider these factors. This analysis is part of a comprehensive 80-parameter fundamental audit, verified by Sweta Mishra, and aims to provide an objective assessment of Hemadri Cements' financial health based on publicly available data. The information presented is purely observational and does not constitute investment advice.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Hemadri Cements Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of HEMACEM across key market metrics for learning purposes.
Positive Indicators
3 factors identified
Robust Profit Growth (35.59%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Balanced Promoter Holding (66.31%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
9 factors identified
Below-Average Return on Equity (-281.44%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (-77.44%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Margin Pressure Concerns (-13.82%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges.
Revenue Contraction (-100.00%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Limited Growth History (-35.30% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.
Weak Interest Coverage (-7.40x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
Negative Free Cash Flow (₹-11.87 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Limited Institutional Interest (FII+DII: 0.01%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Hemadri Cements Ltd Financial Statements
Comprehensive financial data for Hemadri Cements Ltd including income statement, balance sheet and cash flow
About HEMACEM (Hemadri Cements Ltd)
Hemadri Cements Ltd (HEMACEM) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Cement & Cement Products sector with a current market capitalisation of ₹33.94 (Cr). Hemadri Cements Ltd has delivered a Return on Equity (ROE) of -281.44% and a ROCE of -77.44%. Investors tracking HEMACEM share price can monitor key metrics including P/E ratio, promoter holding of 66.31%, and quarterly earnings growth.
Company Details
Key Leadership
HEMACEM Share Price: Frequently Asked Questions
What is the current share price of Hemadri Cements Ltd (HEMACEM)?
As of 02 Jan 2026, 04:27 pm IST, Hemadri Cements Ltd share price is ₹50.88. The HEMACEM stock has a market capitalisation of ₹33.94 (Cr) on NSE/BSE.
Is HEMACEM share price Overvalued or Undervalued?
HEMACEM share price is currently trading at a P/E ratio of 0.00x, compared to the industry average of 33.70x. Based on this relative valuation, the Hemadri Cements Ltd stock appears to be Fairly Valued against its sector peers.
What is the 52-week high and low of HEMACEM share price?
The 52-week high of HEMACEM share price is ₹N/A and the 52-week low is ₹N/A.
What factors affect the Hemadri Cements Ltd share price?
Key factors influencing HEMACEM share price include quarterly earnings growth (Sales Growth: -100.00%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Hemadri Cements Ltd a good stock for long-term investment?
Hemadri Cements Ltd shows a 5-year Profit Growth of N/A% and an ROE of -281.44%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of N/A before investing in HEMACEM shares.
How does Hemadri Cements Ltd compare with its industry peers?
Hemadri Cements Ltd competes with major peers in the Cement & Cement Products. Investors should compare HEMACEM share price P/E of 0.00x and ROE of -281.44% against the industry averages to determine competitive standing.
What is the P/E ratio of HEMACEM and what does it mean?
HEMACEM share price has a P/E ratio of N/Ax compared to the industry average of 33.70x. Investors pay ₹N/A for every ₹1 of annual earnings.
How is HEMACEM performing according to Bull Run's analysis?
HEMACEM has a Bull Run fundamental score of 18/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does HEMACEM belong to?
HEMACEM operates in the Cement & Cement Products industry. This classification helps understand the competitive landscape and sector-specific trends affecting Hemadri Cements Ltd share price.
What is Return on Equity (ROE) and why is it important for HEMACEM?
HEMACEM has an ROE of -281.44%, which suggests challenges in generating returns from shareholders equity. ROE measures how efficiently Hemadri Cements Ltd generates profits from shareholders capital.
How is HEMACEM debt-to-equity ratio and what does it indicate?
HEMACEM has a debt-to-equity ratio of N/A, which indicates conservative financing with low financial risk.
What is HEMACEM dividend yield and is it a good dividend stock?
HEMACEM offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Hemadri Cements Ltd shares.
How has HEMACEM share price grown over the past 5 years?
HEMACEM has achieved 5-year growth rates of: Sales Growth -35.30%, Profit Growth N/A%, and EPS Growth N/A%.
What is the promoter holding in HEMACEM and why does it matter?
Promoters hold 66.31% of HEMACEM shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Hemadri Cements Ltd.
What is HEMACEM market capitalisation category?
HEMACEM has a market capitalisation of ₹34 crores, placing it in the Small-cap category.
How volatile is HEMACEM stock?
HEMACEM has a beta of N/A. A beta > 1 suggests the Hemadri Cements Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is HEMACEM operating profit margin trend?
HEMACEM has a 5-year average Operating Profit Margin (OPM) of -13.82%, indicating the company's operational efficiency.
How is HEMACEM quarterly performance?
Recent quarterly performance shows Hemadri Cements Ltd YoY Sales Growth of -100.00% and YoY Profit Growth of 35.59%.
What is the institutional holding pattern in HEMACEM?
HEMACEM has FII holding of 0.00% and DII holding of 0.01%. Significant institutional holding often suggests professional confidence in the Hemadri Cements Ltd stock.